University of Florida
Gainesville, Florida, 32610, United States
NCT Number: NCT02300272
This is a single-center, observational study design. Enrolled participants will be typically, healthy older adults. Participants will complete daily computerized measures, in addition to continuously wearing an Actiwatch device. The study period will last 2 weeks. The objectives of the study are to examine the impact of sleep, pain, and circadian rhythm on practice-related learning in older adults at their preferred versus nonpreferred times of day.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Gainesville, Florida, 32610, United States
Participants will be asked to review the informed consent and consent to the study prior to any study procedure.
There are four stages to this study: 1. a telephone interview, 2. an in-person interview and completion of questionnaires, 3. an in-home single night sleep recording, and 4. two weeks of computerized cognitive testing, subjective sleep and pain recordings, and wearing a Actiwatch.
During the telephone interview, participants will be asked question about their age, sleep, pain, and medical/mental health history. At a second visit, participants will complete a more in-depth interview of their physical health, mental health, sleep, and pain history. They will complete a brief test of their cognitive functioning. They will also complete 4 questionnaires about their time of day preference and mood. At the third visit, participants will visit the University of Florida to be connected to a machine which will monitor their sleep. Participants will return home to sleep while still connected to the machine and will return the machine to the University of Florida the next day. Participants will complete brief computerized daily questionnaires of sleep and pain and cognitive testing in the morning and evening, and and wear an actigraph (wristwatch-like device) that measures arm movements and ambient light for two weeks.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be screened for sleep disorders other than chronic insomnia with an in-home overnight sleep monitoring. Monitoring will consist of six electroencephalography (EEG) measures, two electrooculography (EOG), and chin electromyography (EMG) according to standard placements. Other channels will include oxygen saturation level, bilateral anterior tibialis EMG, heart rate (EKG), thoracic strain gauge, and a nasal/oral thermistor. A single night of polysomnography will be collected during the 2 weeks of assessment.
Other names: AURA Recording System, Grass Technologies
This device will be worn on the wrist for 14 continuous days to measure limb movements and ambient light.
Other names: Actiwatch-L, Mini Mitter
Time frame: Morning and evening completion for 14 days
Cognitive domains include processing speed, immediate memory, delayed memory, and executive function
University of Florida
Other
Modifiable Health Behaviors Associated With Time-of-Day Differences in Older Adults' Practice-Related Learning
Acronym: OA-TIME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02486328
Alteration of Cognitive Function, Cognition Disorders
View Trial DetailsNCT02847793
Alteration of Cognitive Function, Behavior
Madrid, Spain
View Trial DetailsNCT02958735
Alteration of Cognitive Function, Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT01429103
Age-associated Memory Impairment, Alteration of Cognitive Function
Rochester, New York, United States
View Trial Details